National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
75.56
-1.21 (-1.58%)
At close: May 12, 2025, 4:00 PM
75.56
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
National Health Investors Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for National Health Investors stock have an average target of 82.2, with a low estimate of 69 and a high estimate of 92. The average target predicts an increase of 8.79% from the current stock price of 75.56.
Analyst Consensus: Buy
* Price targets were last updated on Mar 19, 2025.
Analyst Ratings
The average analyst rating for National Health Investors stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $70 → $76 | Hold | Maintains | $70 → $76 | +0.58% | Mar 19, 2025 |
| Wedbush | Wedbush | Buy Reiterates $88 | Buy | Reiterates | $88 | +16.46% | Mar 17, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | -4.71% | Dec 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Initiates $81 → $86 | Buy → Hold | Initiates | $81 → $86 | +13.82% | Oct 1, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $92 | Strong Buy | Initiates | $92 | +21.76% | Sep 24, 2024 |
Financial Forecast
Revenue This Year
358.29M
from 335.58M
Increased by 6.77%
Revenue Next Year
400.43M
from 358.29M
Increased by 11.76%
EPS This Year
3.15
from 3.13
Increased by 0.61%
EPS Next Year
3.32
from 3.15
Increased by 5.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 416.8M | 512.5M | 601.7M | ||
| Avg | 358.3M | 400.4M | 437.6M | ||
| Low | 325.3M | 337.6M | 342.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.2% | 43.0% | 50.3% | ||
| Avg | 6.8% | 11.8% | 9.3% | ||
| Low | -3.1% | -5.8% | -14.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.42 | 3.61 | 3.50 |
| Avg | 3.15 | 3.32 | 3.36 |
| Low | 2.95 | 3.12 | 3.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.4% | 14.7% | 5.2% |
| Avg | 0.6% | 5.5% | 1.2% |
| Low | -5.8% | -1.0% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.